Business:
Therapies for Sanfilippo (SF) Syndrome Type A and Type B.
Drug notes:
AB0-504 RD/Clin0 Stargardt disease; ABO-503 RD/Clin0 x-linked retinoschisis; ABO-505 RD/Clin0 autosomal dominant optic atrophy; AIM Vectors RD undisclosed
About:
Abeona Therapeutics is developing cell and gene therapies for patients with serious diseases. Delivery of gene therapies to the desired tissue without causing an immune response is important for their success. Abeona is using their next-generation adeno-associated viruses (AAVs) to selectively deliver genetic payloads to the central nervous system, lungs, eyes, muscle, liver and other tissues. Abeona’s AAVs are non-replicating and have shown potential to evade immune responses generated by exposure to naturally-occuring AAV vectors. Abeona is applying their AAV technology for several diseases with therapies already in clinical trials. This includes EB-101, in Phase III trials for patients with Epidermolysis Bullosa and other undisclosed targets in preclinical phases.
Associate Director, Engineering Cleveland, OH|2 days ago
Senior Validation Engineer Cleveland, OH|2 days ago
Senior Manager/Associate Director, Medical Writer Remote|21 days ago
Inventory Logistics Associate Cleveland, OH|35 days ago
Manager, Quality Assurance Cleveland, OH|43 days ago
Document Control/Archivist Specialist I, Quality A... Cleveland, OH|43 days ago
Analyst Quality Control Micro Analytical Cleveland, OH|44 days ago
Associate, Manufacturing - Operations Cleveland, OH|45 days ago
Quality Control Analyst I (QC Analytical) Cleveland, OH|58 days ago
Sr. Analyst, Quality Control Cleveland, OH|66 days ago
Sr. Manager, Clinical / Non-Clinical Quality Cleveland, OH|66 days ago